Literature DB >> 27083463

Radon testing in rapid access lung clinics: an opportunity for secondary prevention.

R Smyth1, S Long2, E Wiseman3, D Sharpe3, D Breen3, A O'Regan3.   

Abstract

BACKGROUND: Radon is a naturally occurring radioactive gas and a level 1 carcinogen. It acts synergistically with cigarette smoke to cause lung cancer. In Ireland, radon is estimated to be associated with 13 % of all lung cancers. Rapid access lung cancer clinics (RALC's) were established in the UK and Ireland to improve lung cancer management outcomes. There has been no attempt to date to provide advice on household radon exposure assessments in this setting. AIMS: We performed a prospective feasibility study of radon assessment in our RALC to test the hypothesis that patients would avail of this service and that it would provide an opportunity for secondary prevention in at risk persons.
METHODS: We investigated household radon levels in consecutive patients who were newly referred with symptoms of lung cancer to the RALC in Galway University Hospital, Ireland over a 6-month period.
RESULTS: Of 50 patients enrolled, 42 returned valid results. Overall 21 % of patients had radon levels recorded above the national reference level. Only 5 % of patients were aware of the association between radon gas and lung cancer. Smokers were significantly less likely to engage fully in radon testing.
CONCLUSIONS: The development of RALC's offers a novel opportunity to integrate the concepts of radon exposure, cigarette smoking and the development of lung cancer, and to reinforce this message in the minds of at risk patients.

Entities:  

Keywords:  Lung cancer; Radon; Screening; Smoking; Smoking cessation

Mesh:

Substances:

Year:  2016        PMID: 27083463     DOI: 10.1007/s11845-016-1448-0

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  7 in total

1.  Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies.

Authors:  S Darby; D Hill; A Auvinen; J M Barros-Dios; H Baysson; F Bochicchio; H Deo; R Falk; F Forastiere; M Hakama; I Heid; L Kreienbrock; M Kreuzer; F Lagarde; I Mäkeläinen; C Muirhead; W Oberaigner; G Pershagen; A Ruano-Ravina; E Ruosteenoja; A Schaffrath Rosario; M Tirmarche; L Tomásek; E Whitley; H-E Wichmann; R Doll
Journal:  BMJ       Date:  2004-12-21

2.  Evaluating the health benefits and cost-effectiveness of the radon remediation programme in domestic properties in Northamptonshire, UK.

Authors:  Antony Denman; Christopher Groves-Kirkby; Thomas Coskeran; Steven Parkinson; Paul Phillips; Roges Tornberg
Journal:  Health Policy       Date:  2004-12-08       Impact factor: 2.980

3.  Radon, smoking, and lung cancer: the need to refocus radon control policy.

Authors:  Paula M Lantz; David Mendez; Martin A Philbert
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

4.  Influences motivating smokers in a radon-affected area to quit smoking.

Authors:  Christopher J Groves-Kirkby; Karen Timson; George Shield; Antony R Denman; Stephen Rogers; Jackie Campbell; Paul S Phillips; Merryn Ekberg
Journal:  Perspect Public Health       Date:  2012-07-27

Review 5.  Systematic review of multidisciplinary teams in the management of lung cancer.

Authors:  M Coory; P Gkolia; I A Yang; R V Bowman; K M Fong
Journal:  Lung Cancer       Date:  2008-03-04       Impact factor: 5.705

6.  Home energy efficiency and radon related risk of lung cancer: modelling study.

Authors:  James Milner; Clive Shrubsole; Payel Das; Benjamin Jones; Ian Ridley; Zaid Chalabi; Ian Hamilton; Ben Armstrong; Michael Davies; Paul Wilkinson
Journal:  BMJ       Date:  2014-01-10

7.  Perceived risk of exposure to indoor residential radon and its relationship to willingness to test among health care providers in Tehran.

Authors:  Narjes Hazar; Mojgan Karbakhsh; Masud Yunesian; Saharnaz Nedjat; Kazem Naddafi
Journal:  J Environ Health Sci Eng       Date:  2014-08-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.